Michael Cherny

Stock Analyst at Leerink Partners

(1.25)
# 2047
Out of 5,441 analysts
163
Total ratings
Success rate
Average return
35 Stocks
Name Action PT Current % Upside Ratings Updated
CAH Cardinal Health
Maintains: Outperform
188 186
157.91 17.79% 10 Aug 12, 2025
PGNY Progyny
Upgrades: Outperform
28
21.75 28.74% 11 Jul 8, 2025
BOLD Boundless Bio
Downgrades: Market Perform
15 3
1.1 172.73% 2 May 28, 2025
MCK McKesson
Maintains: Strong Buy
755 800
672.98 18.87% 10 May 9, 2025
NVST Envista Holdings
Maintains: Buy
26 23
20.19 13.92% 11 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
330
449.72 -26.62% 1 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
24 40
49.96 -19.94% 10 Feb 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
55 75
64.91 15.54% 11 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
60 90
61.88 45.44% 2 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 8 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
235 280
134.92 107.53% 2 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
135 174
178.34 -2.43% 2 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
69 84
66.11 27.06% 2 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
29 32
31.33 0.06% 18 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
260 248
180.09 37.71% 2 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
270 255
159.85 59.52% 3 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 7 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
277 275
290.78 -5.43% 3 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
17 15
n/a n/a 5 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
23 22
11.87 85.34% 2 Mar 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
260
267.87 -2.94% 1 Feb 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
23
23.36 -3.68% 4 Feb 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
3.49 129.23% 5 Feb 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
19
10.46 81.64% 1 Feb 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
17
6.78 150.74% 1 Feb 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
195 200
179.98 11.12% 13 Jun 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
2
n/a n/a 1 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
5
n/a n/a 1 Jan 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
113 53
5.77 809.88% 2 Jan 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3000
n/a n/a 1 Nov 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
n/a n/a 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
30.49 11.51% 1 Mar 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 4 Jan 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 17
n/a n/a 4 Nov 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Underperform
51
n/a n/a 1 Aug 19, 2020